Clinical Research Directory
Browse clinical research sites, groups, and studies.
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Sponsor: Fondation FondaMental
Summary
The goal of this study is to learn whether people living with severe psychiatric disorders can be grouped into more homogeneous subgroups, across usual diagnostic categories, based on two key dimensions: social withdrawal and anhedonia (reduced ability to feel pleasure). The study includes adolescents and adults aged 15 to 60 with schizophrenia, a first psychotic episode, bipolar disorder, recurrent or treatment-resistant major depressive disorder, or autism spectrum disorder without intellectual disability, as well as healthy volunteers aged 18 to 60. The main questions it aims to answer are: * Can subgroups of patients sharing a common profile of social withdrawal and anhedonia be identified, with similar clinical, genetic, biological and brain imaging characteristics? * Do other dimensions (cognitive flexibility, neurodevelopmental, sensory and sleep disturbances, impulsivity) and specific clinical forms (e.g., autoimmune psychosis, metabolic abnormalities) define relevant subgroups, and how do these subgroups evolve over time? Researchers will compare patients with healthy volunteers to identify clinical and biological signatures specific to each subgroup. Participants will: * Attend an inclusion visit, two one-day assessment visits one year apart (clinical interviews, questionnaires, cognitive tests, fasting blood sample) and two brain MRI sessions * Optionally provide a stool sample collected at home * Complete questionnaires on a smartphone app and wear a connected watch (activity, sleep, heart rate) between visits * Take part in the study for about 18 months French Minds is conducted in about 35 centres in France and aims to include 2,500 patients and 500 healthy volunteers.
Official title: Cohorte française Longitudinale et Multimodale de Patients Atteints de Troubles Majeurs de l'Humeur, de Troubles Psychotiques, de Troubles du Spectre de l'Autisme et de témoins
Key Details
Gender
All
Age Range
15 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
3000
Start Date
2026-06-11
Completion Date
2031-06
Last Updated
2026-10-19
Healthy Volunteers
Yes
Conditions
Interventions
3T Brain MRI
Structural and functional 3T brain MRI (about 1 hour), performed at baseline (within 6 weeks of V1) and at 1-year follow-up (within 6 weeks of V3), using a protocol harmonised across sites by the CATI platform.
Biological Sampling
Fasting blood sample for research at V1 and V3 (genomics, transcriptomics, epigenetics, metabolomics, proteomics, immune and inflammatory markers, autoantibodies). Optional home stool collection at V1 and V3 for gut microbiome analysis.
Clinical, Cognitive and Digital Assessments
Standardised psychiatric interviews and rating scales, self-questionnaires, neuropsychological testing, physical and minor neurological examination at V1 and V3; digital phenotyping over one year using a study-provided smartphone (Kanopsy app) and a connected watch (activity, sleep, heart rate variability).
Locations (17)
CHU de Besançon
Besançon, France
Centre Hospitalier Charles Perrens
Bordeaux, France
CHU de Brest
Brest, France
Centre Hospitalier Le Vinatier
Bron, France
CHU Clermont Ferrand
Clermont-Ferrand, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Hopital Louis Mourier
Colombes, France
Hopital Albert Chenevier
Créteil, France
CHU Grenoble Alpes - Hôpital Nord
Grenoble, France
CHU de Lille
Lille, France
Hopital Sainte-Marguerite
Marseille, France
CHU de Montpellier
Montpellier, France
GHU Sainte-Anne
Paris, France
Hopital Lariboisière
Paris, France
CHU de Saint-Étienne
Saint-Etienne, France
CHU de Toulouse
Toulouse, France
CHU de Tours
Tours, France